The Asian Menopause Survey: Knowledge, perceptions, hormone treatment and sexual function

被引:84
作者
Huang, Ko-En [1 ,2 ]
Xu, Ling [3 ]
Nasri, Nik, I [4 ]
Jaisamrarn, Unnop [5 ]
机构
[1] Chang Gung Univ, Kaohsiung Med Ctr, Chang Gung Mem Hosp, Ctr Menopause & Reprod Med Res,Coll Med, Kaohsiung 83305, Taiwan
[2] Chang Gung Univ, Kaohsiung Med Ctr, Chang Gung Mem Hosp, Dept Obstet & Gynecol,Coll Med, Kaohsiung 83305, Taiwan
[3] Chinese Acad Med Sci, Peking Union Coll Hosp, Dept Obstet & Gynecol, Beijing 100037, Peoples R China
[4] Univ Sains Islam Malaysia, Dept Obstet & Gynecol, Fac Med & Hlth Sci, Persiaran MPAJ, Kuala Lumpur, Malaysia
[5] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand
关键词
Menopause; Breast cancer; Survey; Compliance; Sexual function; Hormone replacement therapy; REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; SYMPTOMS; PRESCRIPTION; ESTROGEN; TAIWAN; AGE;
D O I
10.1016/j.maturitas.2009.11.015
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To provide current insights into the opinions, attitudes, and knowledge of menopausal women in Asia regarding menopause and hormone replacement therapy (HRT). Study design: Cross-sectional. Main outcome measures: Between January 2006 and February 2006, 1000 postmenopausal women from China, Malaysia, Taiwan, Thailand and Hong Kong were interviewed to determine postmenopausal symptoms, HRT use and knowledge, breast discomfort and knowledge of breast cancer risks; and sexual function. Results: Almost all women reported experiencing postmenopausal symptoms. Sleeplessness (42%) was reported as the main reason for seeking treatment. On average, 54% of women were aware of HRT, despite the fact that most (38%) were unable to mention any associated benefits. Most women had used natural or herbal treatments (37%) for the alleviation of menopausal symptoms. Only 19% had received HRT. 27% of respondents reported having breast discomfort, while 70% reported performing self-breast examinations. 53% of women had never received a mammogram, despite breast cancer concern (50%). 24% of women described HRT as being a risk factor for breast cancer. Most women and their partners reported no reductions in sexual function (66 and 51%, respectively), while 90% of respondents did not seek treatment for reduced sexual function. In the event of sexual dysfunction, 33% of women replied that they would be willing to seek treatment. Conclusions: Many Asian women experience postmenopausal symptoms that are often left untreated (due to the acceptance of menopause as a natural process) or treated with herbal/natural remedies. There was a general lack of knowledge among these women regarding treatment options, HRT, and possible risks associated with HRT. A more concerted effortshould be made to better disseminate information regarding the pathogenesis and risk factors associated with breast cancer, menopause, and menopausal symptoms to Asian women. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 15 条
  • [1] Beral Valerie, 2003, Lancet, V362, P419
  • [2] Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
  • [3] Chaikittisilpa Sukanya, 2007, Journal of the Medical Association of Thailand, V90, P628
  • [4] The European Menopause Survey 2005: Women's perceptions on the menopause and postmenopausal hormone therapy
    Genazzanii, Andrea R.
    Schneider, Hermann P. G.
    Panay, Nick
    Nijland, Esme A.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (07) : 369 - 375
  • [5] Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
    Grady, D
    Herrington, D
    Bittner, V
    Blumenthal, R
    Davidson, M
    Hlatky, M
    Hsia, J
    Hulley, S
    Herd, A
    Khan, S
    Newby, LK
    Waters, D
    Vittinghoff, E
    Wenger, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01): : 49 - 57
  • [6] Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: The Pan-Asia menopause (PAM) study
    Haines, CJ
    Xing, SM
    Park, KH
    Holinka, CF
    Ausmanas, MK
    [J]. MATURITAS, 2005, 52 (3-4) : 264 - 276
  • [7] National use of postmenopausal hormone therapy - Annual trends and response to recent evidence
    Hersh, AL
    Stefanick, ML
    Stafford, RS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01): : 47 - 53
  • [8] Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
    Huang, Weng-Foung
    Tsai, Yi-Wen
    Hsiao, Fei-Yuan
    Liu, Wen-Chun
    [J]. BMC PUBLIC HEALTH, 2007, 7 (1)
  • [9] Hormone therapy use and prescription durations of menopausal women in Taiwan: A 5 years' National Cohort study
    Kuo, De-Jhen
    Lee, Yue-Chune
    Huang, Weng-Foung
    [J]. MATURITAS, 2007, 58 (03) : 259 - 268
  • [10] Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years
    Lam, PM
    Leung, TN
    Haines, C
    Chung, TKH
    [J]. MATURITAS, 2003, 45 (02) : 99 - 107